Premium
Synthesis and characterization of 7α‐O‐iodoallyl diprenorphine: A new ligand for potential spect imaging of opioid receptors
Author(s) -
Wang R. F.,
Tafani J. A. M.,
Bergon M.,
Tisnes P.,
Coulais Y.,
Zajac J. M.,
Guiraud R.
Publication year - 1995
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.2580360702
Subject(s) - diprenorphine , chemistry , radioligand , opioid receptor , ligand (biochemistry) , receptor , opioid , spect imaging , antagonist , stereochemistry , radiosynthesis , radiochemistry , nuclear medicine , positron emission tomography , biochemistry , medicine
The preparation and synthesis of [ 125 I]7α‐O‐iodoallyl diprenorphine, a high affinity opioid receptor antagonist, is described using a versatile vinylstannane as prosthetic group for radioiodination at the tertiary alcohol group in the 7α‐side chain. Radioiododestannylation with selective conditions in one step occurs under mild, no‐carrier‐added‐conditions to give the corresponding [ 125 I]7α‐O‐iodoallyl diprenorphine analogue in good radiolabelled yields (70‐90%) with specific radioactivity 80 TBq/mmol (2200 Ci/mmol) and radiochemical purity > 95%. Iodoallyl diprenorphine exhibited in vitro a very high affinity (K i = 0.4 nM), so that this radioligand could be suitable for imaging opioid receptors in living humans by Single Photon Emission Computed Tomography (SPECT).